Theravance Biopharma, Inc. — filings

TBPH · CIK 1583107

Aggregates

computed from the filings below
Documents on record
3
Form types used
2
Filed in last 12 months
3
Median interval
24 d
between consecutive filings
Most used form
8-K
2 filings
Most recent filing
2026-09-18
Filed on a Friday
1
of the filings shown
Earliest shown
2026-08-11

By form type

FormFilingsMost recent
8-K22026-09-18
10-Q12026-08-11

Documents

3 most recent shown
FiledFormAccessionSource
2026-09-188-K0001104659-26-108980document
2026-08-258-K0001104659-26-100860document
2026-08-1110-Q0001104659-26-093773document

Source: U.S. Securities and Exchange Commission, EDGAR

Theravance Biopharma, Inc. filings — 3 documents on record — investment.com